LAURUS LABS
|
|
BOM : 540222     NSE : LAURUSLABS     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : None or < 25% |
May 29,2023 |
Price(EOD): βΉ 334.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 18,022.21 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
LAURUS LABS | 6.3% | 14.5% | -40.9% |
SUN PHARMACEUTICAL INDUSTRIES | 4% | -1.1% | 6.6% |
DIVIS LABORATORIES | 2.8% | 7.5% | -4.1% |
CIPLA | 2.7% | 4.6% | -2% |
DR REDDYS LABORATORIES | 2.2% | -7.4% | 4.1% |
TORRENT PHARMACEUTICALS | 0.8% | 4.6% | 31.3% |
ABBOTT INDIA | 1.8% | -1.2% | 20.3% |
ZYDUS LIFESCIENCES | 1% | -0.6% | 37.9% |
ALKEM LABORATORIES | 2.9% | -2.4% | 14.1% |
FUNDAMENTAL ANALYSIS OF LAURUS LABS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF LAURUS LABS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
22.62
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 796.64 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] 4.46
P/B Calculated based on Book Value of Rs 4,037.53 Cr
[Latest Year - Mar2023 - Consolidated Results ] 2.98
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 6,040.55 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-20% -5% -3% |
SHARE PRICE MOMENTUM OF LAURUS LABS
LAURUS LABS vs SENSEX
DEBT OF LAURUS LABS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.48 0.51 0.57 0.52 |
0.52 0.56 0.6 0.56 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF LAURUS LABS
Pledged Promoter Shares |
0.04 % | |
---|---|---|
As on : Mar2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF LAURUS LABS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-10.61% -29.25% -47.04% -47.19% |
-3.08% -28.02% -51.23% -53.76% |
QtrlyTrend |
-8 | |
Latest Qtr: Mar2023 | ||
Quarterly Result Analysis → |
LAURUS LABS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDCAP SELECT INDEX | 2.5% | 10% | 12% |
S&P BSE HEALTHCARE | 2.2% | 3.8% | 3.8% |
S&P BSE MID CAP | 2.2% | 7.5% | 19.9% |
S&P BSE 150 MIDCAP | 1.9% | 6.5% | 18.3% |
S&P BSE 200 | 1.8% | 5.1% | 13.7% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY PHARMA | 3.1% | 1.3% | -2.1% |
NIFTY FREE MIDCAP 100 | 2.4% | 7.4% | 20.8% |
NIFTY HEALTHCARE | 2.4% | 3.7% | 3.3% |
NIFTY MIDCAP150 | 2.2% | 6.7% | 20.3% |
NIFTY LARGE MIDCAP 250 | 1.9% | 5.8% | 16.5% |
You may also like the below Video Courses
FAQ about LAURUS LABS
Is LAURUS LABS good for long term investment?
As on May 29,2023, the Fundamentals of LAURUS LABS look Strong and hence it may be good for long term investment! See Financial Performance of LAURUS LABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is LAURUS LABS UnderValued or OverValued?
As on May 29,2023, LAURUS LABS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of LAURUS LABS ?
As on May 29,2023, the Intrinsic Value of LAURUS LABS is Rs. 350.76 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 415.78
Fair Value [Median EV / Sales Model] : Rs. 350.76
Fair Value [Median Price / Sales Model] : Rs. 346.00
Estimated Median Fair Value of LAURUS LABS : Rs. 350.76
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is LAURUS LABS trading at a Premium or Discount?
As on May 29,2023, LAURUS LABS is trading at a Discount of -5% based on the estimates of Median Intrinsic Value!